Supramolecular Self-Assembled Peptide-Based Vaccines: Current State and Future Perspectives

Area of Science:

• Biomaterials Science
• Nanotechnology
• Immunology

Background:

• Vaccines are crucial for preventing infectious diseases, but effective vaccines for pathogens like HIV remain elusive.
• Biomaterials are increasingly used to enhance vaccine safety and efficacy in immunotherapies.
• Self-assembling peptides offer a promising avenue for developing next-generation vaccines.

Purpose of the Study:

• To review the types of self-assembled peptides and their nanostructures for vaccine development.
• To discuss recent advancements, challenges, and future directions in peptide-based vaccines.
• To highlight the potential of stimuli-responsive peptide biomaterials in vaccine delivery and immunostimulation.

Main Methods:

• Review of current literature on self-assembled peptide nanostructures in vaccine research.
• Analysis of peptide self-assembly into various forms (nanofibers, nanotubes, hydrogels).
• Evaluation of peptide nanostructures for antigen presentation, stability, and controlled release of immunomodulators.

Main Results:

• Self-assembled peptides form diverse nanostructures with tunable properties.
• These nanostructures enhance antigen presentation, enzymatic stability, and biocompatibility.
• Peptide-based systems enable controlled delivery and targeted immunostimulation.

Conclusions:

• Self-assembled peptides represent a significant advancement in biomaterials for vaccine development.
• These materials offer innovative solutions for creating effective vaccines against difficult pathogens.
• Further research and clinical translation are essential for realizing the full potential of peptide-based vaccines.